These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status. Nakamura T, Seto M, Tajika M, Kawai H, Yokoi T, Yatabe Y, Nakamura S. Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851 [Abstract] [Full Text] [Related]
7. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma. Streubel B, Ye H, Du MQ, Isaacson PG, Chott A, Raderer M. Oncology; 2004 Jan; 66(6):476-80. PubMed ID: 15452377 [Abstract] [Full Text] [Related]
13. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis. Al-Taie O, Al-Taie E, Fischbach W. Z Gastroenterol; 2014 Dec; 52(12):1389-93. PubMed ID: 25474277 [Abstract] [Full Text] [Related]
14. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma. Gisbert JP, Calvet X. Aliment Pharmacol Ther; 2011 Nov; 34(9):1047-62. PubMed ID: 21919927 [Abstract] [Full Text] [Related]
16. [Crucial roles of Helicobacter pylori infection in the pathogenesis of gastric cancer and gastric mucosa-associated lymphoid tissue (MALT) lymphoma]. Ota H, Asano N, Yamauchi K, Akamatsu T. Rinsho Byori; 2009 Sep; 57(9):861-9. PubMed ID: 19860212 [Abstract] [Full Text] [Related]